Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Autofluorescence endoscopy improves Barrett's diagnosis

The latest Endoscopy shows that autofluorescence endoscopy vs standard 4-quadrant biopsy improves diagnostic yield for neoplasia in Barrett's esophagus.

News image

fiogf49gjkf04

The reference surveillance method in patients with Barrett's esophagus is careful endoscopic observation, with targeted as well as random 4-quadrant biopsies.

Autofluorescence endoscopy may make it easier to locate neoplasia.

Dr Borovicka and colleagues from Switzerland elucidated the diagnostic accuracy of surveillance with Autofluorescence endoscopy-guided plus 4-quadrant biopsies vs the conventional approach.

The research team enrolled a total of 187 of 200 consecutive Barrett's esophagus patients.

Of these patients, 73% were male with a mean age 67 years, who underwent endoscopy for Barrett's esophagus in 4 study centers.

In phase 1, patients were randomly assigned to either-targeted biopsy followed by 4-quadrant biopsies or conventional endoscopic surveillance with 4-quadrant biopsies.

The team excluded patients with early cancer or high-grade dysplasia, who underwent endoscopic or surgical treatment.

Autofluorescence endoscopy yielded high-grade dysplasia rates of 12%
Endoscopy

Patients who declined to participate in phase 2 of the study were also excluded.

The research team reported that 130 patients remained.

These patients were examined again with the alternative method after a mean of 10 weeks, using the same methods described.

The team's main study parameter was the detection of early cancer, adenocarcinoma or high-grade dysplasia.

The secondary aim in the second phase was the additional value of the Autofluorescence endoscopy-guided approach after conventional surveillance.

The researchers derived test accuracy measures from the first study phase.

The research team found that the Autofluorescence endoscopy yielded adenocarcinoma/high-grade dysplasia at rates of 12%.

The team noted that conventional approaches yielded adenocarcinoma/high-grade dysplasia rates of 5% on a per-patient basis.

With Autofluorescence endoscopy, previously unrecognized adenocarcinoma or high-grade dysplasia lesions were identified in 4% of the patients.

The researchers observed new lesions in 1% with the conventional approach.

Of the 19 adenocarcinoma/high-grade dysplasia lesions detected during Autofluorescence endoscopy in the first study phase, 8 were visualized.

A further 11 were only detected using untargeted 4-quadrant biopsies, giving a sensitivity of 42%.

Of the 766 biopsies classified at histology as being nonneoplastic, 58 appeared suspicious.

The specificity was 92%, with a positive predictive value of 12%, and a negative predictive value 99%.

In the second phase using Autofluorescence endoscopy, the team detected 2 further lesions in addition to the initial alternative approach in 3% of cases.

Conventional endoscopy identified only 2% of lesions.

Dr Borovicka's team concluded, “In this referral Barrett's esophagus population with a higher prevalence of neoplastic lesions, the Autofluorescence endoscopy -guided approach improved the diagnostic yield for neoplasia.”

“In comparison with the conventional approach using 4-quadrant biopsies.”

“However, Autofluorescence endoscopy alone was not suitable for replacing the standard 4-quadrant biopsy protocol.”

Endoscopy 2006: 38(9): 867-72
26 September 2006

Go to top of page Email this page Email this page to a colleague

 19 January 2018 
Ileoanal pouch microbiota
 19 January 2018 
Predicting the risk of early surgery in Crohn’s
 19 January 2018 
Lifestyle intervention vs gastric bypass for obesity and diabetes
 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us